immunoprop: Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

Sponsor
New York CFS Association (Other)
Overall Status
Unknown status
CT.gov ID
NCT01893619
Collaborator
(none)
100
1
6
16.6

Study Details

Study Description

Brief Summary

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Detailed questionnaire regarding the diagnosis of an onset of chronic fatigue syndrome and 100 patients. using Karnofsky scale before and after use of supplements patient scores are compared in a double blind trial.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome
    Study Start Date :
    Jun 1, 2013
    Anticipated Primary Completion Date :
    Dec 1, 2013
    Anticipated Study Completion Date :
    Dec 1, 2013

    Outcome Measures

    Primary Outcome Measures

    1. Karnovsky score comparison [Six months]

      Review of Karnofsky score over prior to diagnosis and subsequent to patients having taken supplements

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection
    Exclusion Criteria:
    • non inclusion in the above criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Me/Cfs Center,860 Fifth Avenue New York New York United States 10065

    Sponsors and Collaborators

    • New York CFS Association

    Investigators

    • Principal Investigator: DEREK enlander, CFIDS RESEARCH FOUNDATION

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    New York CFS Association
    ClinicalTrials.gov Identifier:
    NCT01893619
    Other Study ID Numbers:
    • immunoprop
    First Posted:
    Jul 9, 2013
    Last Update Posted:
    Jul 25, 2013
    Last Verified:
    Jul 1, 2013
    Keywords provided by New York CFS Association
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 25, 2013